水性医薬組成物 - jcr pharma corporation

Title:

水性医薬組成物

Document Type and Number:

Japanese Patent JP7188944

Kind Code:

B2

Abstract:

Aqueous pharmaceutical compositions containing a fusion protein of an antibody and a lysosomal enzyme as an active ingredient, which are stable enough to be marketed, are disclosed. The aqueous pharmaceutical composition, for example, comprises the fusion protein of the antibody and the lysosomal enzyme at a concentration of 0.5 to 20 mg/mL, sodium chloride at a concentration of 0.3 to 1.2 mg/mL, sucrose at a concentration of 50 to 100 mg/mL, a nonionic surfactant at a concentration of 0.15 to 3 mg/mL, a buffer at a concentration of 3 to 30 mM, and is adjusted to pH 5.0 to 7.5.

More Like This:

JP2023517243	Combination therapy and its use with nirogacestat and BCMA-directed therapy
JP7312111	Anti-CCR7 antibody drug conjugate
JP2022137288	HETERODIMERIC FC FUSED CYTOKINES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

Inventors:

Hidehito Yasukawa
Yuka Yamaguchi
Shinji Okabe

Application Number:

JP2018167425A

Publication Date:

December 13, 2022

Filing Date:

September 07, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

jcr pharma corporation

International Classes:

A61K47/68; A61K9/08; A61K38/46; A61K39/395; A61K47/02; A61K47/10; A61K47/26; A61K47/65

Domestic Patent References:

JP2017519009A
JP2016502528A
JP2013534526A

Foreign References:

WO2016208695A1

Other References:

添付文書,エラプレース(登録商標)点滴静注液6mg,2016年07月
添付文書,アクテムラ(登録商標)点滴静注用80mg/アクテムラ(登録商標)点滴静注用200mg/アクテムラ(登録商標)点滴静注用400mg,2016年11月

Attorney, Agent or Firm:

Kei Kobayashi
Yamamoto Yoshiki

Previous Patent: Maintenance and inspection method for unmanned aircraft and structures

Next Patent: NOBLE METAL-PLATED PERSONAL ORNAMENT